Related Funds
| Fund Name | Location |
| 11.2 Capital | California, San Francisco, United States |
| Alphawave group | - |
| Assurance Capital | - |
| BrasilAgro Companhia Brasileira de Propriedades Agricolas | - |
| Bushburg Properties | Brooklyn, New York, United States |
| Centre de Collaboration MiQro Innovation | - |
| Chobe Capital | China, Shanghai |
| FEBO Limited Partnership | - |
| Hoshino Fragment | Japan, Tokyo |
| Rising Capital | Beijing, Beijing, China |
| The Newfoundland and Labrador Association of Technology Industries | Canada, Newfoundland, St. John's |
| The Watermill Group | Lexington, Massachusetts, United States |
| Venture Angels | - |
| Volpe Brown & Whelan | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TriEye | $74M | 10 Nov 2021 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
Biond Biologics | $15M | 03 Nov 2021 | Misgav Regional Council, North District, Israel | ||
Aviv Scientific | $40M | 22 Sep 2021 | Tel Aviv, Tel Aviv, Israel | ||
Ramon.Space | $17M | 25 May 2021 | Palo Alto, California, United States |
– World leader in research and clinical treatment of age-related cognitive and functional decline to maximize human performance, Aviv Scientific, announced the closing of a oversubscribed Series B funding round.
– Led by Israel’s largest public medical services conglomerate, Danel LTD; Jeff Horing’s Deep Insight Fund; the country’s most successful high-tech angels and entrepreneurs; international longevity and healthspan optimization focused investors; the Series B fundraise will accelerate the global rollout of its network of medical clinics and the development of the Aviv Aging Database.
– The application marked the first-time scientists successfully managed to biologically reverse the aging process in healthy humans, using hyperbaric oxygen therapy to lengthen telomeres and reduce senescent cells while also demonstrating cognitive enhancement in healthy adults.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TriEye | $74M | 10 Nov 2021 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
Biond Biologics | $15M | 03 Nov 2021 | Misgav Regional Council, North District, Israel | ||
Aviv Scientific | $40M | 22 Sep 2021 | Tel Aviv, Tel Aviv, Israel | ||
Ramon.Space | $17M | 25 May 2021 | Palo Alto, California, United States |
